CTOs on the Move

Vitamin Angels

www.vitaminangels.org

 
Vitamin Angels is a non-profit organization that distributes lifesaving and life-changing vitamins and minerals to children and mothers in need, working to improve maternal and child nutrition worldwide.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Jewish Hospital and St. Mary's HealthCare, Inc.

Jewish Hospital and St. Mary's HealthCare, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Louisville, KY. To find more information about Jewish Hospital and St. Mary's HealthCare, Inc., please visit www.jhsmh.org

Dedicated Distribution

Dedicated Distribution is a Kansas City, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rodan and Fields

Dr. Katie Rodan and Dr. Kathy Fields met at Stanford University during their dermatology residency bonding over their personal struggles with acne and an understanding of how skin issues impact self-esteem and self-confidence. They combined their personal connection and professional expertise into a shared mission: to provide everyone with life-changing skincareTM that deliver real results! Today, Rodan + Fields has grown from its humble beginnings in Dr. Katie Rodan`s kitchen to the #1 skincare brand in the U.S. in 2016.* We combine our innovative products with a high-tech, high-touch approach, and as a result, more than a million customers have experienced the benefits of Rodan + Fields. We are transforming skincare, and we welcome your big ideas to fuel our ambitious growth plans! If you are looking for a life-changing career opportunity, we`ve got your prescription. At Rodan + Fields, you will be challenged to make an impact, inspired to do more, and rewarded for your contributions.

Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.

Marvin

Marvin is a mental health service for physicians and other healthcare workers, providing personalized teletherapy, meditations, and community programming specifically oriented towards their needs.